Skip to main content
Explore URMC
menu

Shu-Yuan Yeh, Ph.D.

Publications

Showing all 217 journal articles & 9 books available

Journal Articles

11/2108
Xiao Y; Sun Y; Liu G1; Zhao J; Gao Y; Yeh S; Gong L; Chang C. "Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype." Cancer Letter. 2108; .

2/2022
Wang Y, Yang Z, Gu J, Zhang Y, Wang X, Teng Z, Wang D, Gao L, Li W, Yeh S, Han Z. "Estrogen receptor beta increases clear cell renal cell carcinoma stem cell phenotype via altering the circPHACTR4/miR-34b-5p/c-Myc signaling." FASEB journal : official publication of the Federation of American Societies for Experimental Biology.. 2022 Feb 0; 36(2):e22163.

12/17/2021
Gao Y, Ouyang X, Zuo L, Xiao Y, Sun Y, Chang C, Qin X, Yeh S. "R-2HG downregulates ER? to inhibit cholangiocarcinoma via the FTO/m6A-methylated ER?/miR16-5p/YAP1 signal pathway." Molecular therapy oncolytics.. 2021 Dec 17; 23:65-81. Epub 2021 Jul 10.

12/2021
Lu X, Meng J, Su L, Jiang L, Wang H, Zhu J, Huang M, Cheng W, Xu L, Ruan X, Yeh S, Liang C, Yan F. "Multi-omics consensus ensemble refines the classification of muscle-invasive bladder cancer with stratified prognosis, tumour microenvironment and distinct sensitivity to frontline therapies." Clinical and translational medicine. 2021 Dec 0; 11(12):e601.

8/27/2021
He M, Yang H, Shi H, Hu Y, Chang C, Liu S, Yeh S. "Sunitinib increases the cancer stem cells and vasculogenic mimicry formation via modulating the lncRNA-ECVSR/ER?/Hif2-? signaling." Cancer letters.. 2021 Aug 27; Epub 2021 Aug 27.

6/14/2021
Deng G, Wang R, Sun Y, Huang CP, Yeh S, You B, Feng C, Li G, Ma S, Chang C. "Targeting androgen receptor (AR) with antiandrogen Enzalutamide increases prostate cancer cell invasion yet decreases bladder cancer cell invasion via differentially altering the AR/circRNA-ARC1/miR-125b-2-3p or miR-4736/PPAR?/MMP-9 signals." Cell death and differentiation.. 2021 Jun 14; Epub 2021 Jun 14.

2/4/2021
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C. "Corrigendum to: 'New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells'." Journal of molecular cell biology. 2021 Feb 4; Epub 2021 Feb 04.

1/28/2021
You B, Sun Y, Luo J, Wang K, Liu Q, Fang R, Liu B, Chou F, Wang R, Meng J, Huang CP, Yeh S, Chang C, Xu W. "Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR." Oncogene.. 2021 Jan 28; Epub 2021 Jan 28.

1/4/2021
Tian H, Chou FJ, Tian J, Zhang Y, You B, Huang CP, Yeh S, Niu Y, Chang C. "ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling." Journal of experimental & clinical cancer research : CR.. 2021 Jan 4; 40(1):3. Epub 2021 Jan 04.

11/16/2020
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T, . "Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study." The Lancet. Neurology.. 2020 Nov 16; Epub 2020 Nov 16.

11/2/2020
Chou FJ, Lin C, Tian H, Lin W, You B, Lu J, Sahasrabudhe D, Huang CP, Yang V, Yeh S, Niu Y, Chang C. "Preclinical studies using cisplatin/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer." Cell death & disease.. 2020 Nov 2; 11(11):942. Epub 2020 Nov 02.

9/10/2020
Lin C, Chou FJ, Lu J, Lin W, Truong M, Tian H, Sun Y, Luo J, Yang R, Niu Y, Nadal R, Antonarakis ES, Cordon-Cardo C, Sahasrabudhe D, Huang CP, Yeh S, Li G, Chang C. "Preclinical studies show using enzalutamide is less effective in docetaxel-pretreated than in docetaxel-naïve prostate cancer cells." Aging.. 2020 Sep 10; 12Epub 2020 Sep 10.

8/5/2020
Chen D, Chou FJ, Chen Y, Tian H, Wang Y, You B, Niu Y, Huang ZP, Yeh S, Xing N, Chang C. "Targeting the radiation-induced TR4 nuclear receptor-mediated QKI/circZEB1/miR-141-3p/ZEB1 signaling increases prostate cancer radiosensitivity." Cancer letters.. 2020 Aug 5; Epub 2020 Aug 05.

7/2/2020
Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. "Correction to: Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types." Endocrine.. 2020 Jul 2; Epub 2020 Jul 02.

6/25/2020
Liu G, Ouyang X, Sun Y, Xiao Y, You B, Gao Y, Yeh S, Li Y, Chang C. "The miR-92a-2-5p in exosomes from macrophages increases liver cancer cells invasion via altering the AR/PHLPP/p-AKT/?-catenin signaling." Cell death and differentiation.. 2020 Jun 25; Epub 2020 Jun 25.

6/1/2020
Wang K, Luo J, Yeh S, You B, Meng J, Chang P, Niu Y, Li G, Lu C, Zhu Y, Antonarakis ES, Luo J, Huang CP, Xu W, Chang C. "The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer." Nature communications.. 2020 Jun 1; 11(1):2689. Epub 2020 Jun 01.

5/30/2020
Song W, Li L, He D, Xie H, Chen J, Yeh CR, Sien-Shih Chang L, Yeh S, Chang C. "Corrigendum to "Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR)???c-Myc signals" [Cancer Lett. 2015 Nov 1 368(1) 71-78]." Cancer letters.. 2020 May 30; Epub 2020 May 30.

5/14/2020
Gu J, Zhang Y, Han Z, Gao L, Cui J, Sun Y, Niu Y, You B, Huang CP, Chang C, Wang X, Yeh S. "Targeting the ER?/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC." Cell death & disease.. 2020 May 14; 11(5):367. Epub 2020 May 14.

5/1/2020
He M, Yu W, Chang C, Miyamoto H, Liu X, Jiang K, Yeh S. "Estrogen receptor ? increases lung cancer cell invasion via increase of and cross-talk with infiltrated macrophages through the CCL2/CCR2/MMP9 and CXCL12/CXCR4 signaling pathways." Molecular oncology.. 2020 May 1; Epub 2020 May 01.

4/3/2020
Chen J, Sun Y, Ou Z, Yeh S, Huang CP, You B, Tsai YC, Sheu TJ, Zu X, Chang C. "Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion." EMBO reports.. 2020 Apr 3; 21(4):e48467. Epub 2020 Feb 13.

1/29/2020
Xiao Y, Liu G, Sun Y, Gao Y, Ouyang X, Chang C, Gong L, Yeh S. "Targeting the estrogen receptor alpha (ER?)-mediated circ-SMG1.72/miR-141-3p/Gelsolin signaling to better suppress the HCC cell invasion." Oncogene.. 2020 Jan 29; Epub 2020 Jan 29.

9/10/2019
Chen J, Chou F, Yeh S, Ou Z, Shyr C, Huang C, Xiang Z, Sun Y, Messing E, Zu X, Chang C. "Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated G?i protein/MAPK/MMP9 intracellular signaling." Oncogene.. 2019 Sep 10; Epub 2019 Sep 10.

6/24/2019
Huang CP, Chen J, Chen CC, Liu G, Zhang Y, Messing E, Yeh S, Chang C. "ASC-J9® increases the bladder cancer chemotherapy efficacy via altering the androgen receptor (AR) and NF-?B survival signals." Journal of experimental & clinical cancer research : CR.. 2019 Jun 24; 38(1):275. Epub 2019 Jun 24.

6/12/2019
Luo J, Wang K, Yeh S, Sun Y, Liang L, Xiao Y, Xu W, Niu Y, Cheng L, Maity SN, Jiang R, Chang C. "LncRNA-p21 alters the antiandrogen enzalutamide-induced prostate cancer neuroendocrine differentiation via modulating the EZH2/STAT3 signaling." Nature communications.. 2019 Jun 12; 10(1):2571. Epub 2019 Jun 12.

3/20/2019
Zhu W, Zhao Z, Chou F, Zuo L, Liu T, Yeh S, Bushinsky D, Zeng G, Chang C. "Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals." Cell death & disease.. 2019 Mar 20; 10(4):275. Epub 2019 Mar 20.

3/1/2019
Xiao Y, Sun Y, Liu G, Zhao J, Gao Y, Yeh S, Gong L, Chang C. "Androgen receptor (AR)/miR-520f-3p/SOX9 signaling is involved in altering hepatocellular carcinoma (HCC) cell sensitivity to the Sorafenib therapy under hypoxia via increasing cancer stem cells phenotype." Cancer letters.. 2019 Mar 1; 444:175-187. Epub 2018 Nov 15.

1/25/2019
Chang C, Yeh S, Keng P, Li G, Niu Y, Chen D, Chen Y, Chou FJ. "Preclinical study using androgen receptor (AR) degradation enhancer to increase radiotherapy efficacy via targeting radiation-increased AR to better suppress prostate cancer progression." EBioMedicine.. 2019 Jan 25; Epub 2019 Jan 25.

2019
Zhu W, Zhao Z, Chou FJ, Zuo L, Liu T, Bushinsky D, Chang C, Zeng G, Yeh S. "The Protective Roles of Estrogen Receptor in Renal Calcium Oxalate Crystal Formation Reducing the Liver Oxalate Biosynthesis and Renal Oxidative Stress-Mediated Cell Injury." Oxidative medicine and cellular longevity.. 2019 2019:5305014. Epub 2019 Apr 17.

12/28/2018
Niu Y, Guo C, Wen S, Tian J, Luo J, Wang K, Tian H, Yeh S, Chang C. "ADT with antiandrogens in prostate cancer induces adverse effect of increasing resistance, neuroendocrine differentiation and tumor metastasis." Cancer letters.. 2018 Dec 28; 439:47-55. Epub 2018 Sep 15.

12/2018
Song W;, He D;, Chen Y; Yeh CR; Hsu I; Huang Q;, Zhang X; Chang LS; Zuo L;, Chen J; Doersch KM; Chang C; Li L; Yeh S. "Targeting newly identified ER?/TGF-?1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ER? selective antagonist in renal cell carcinoma." Molecular oncology. 2018; .

12/2018
Song W, He D, Chen Y, Yeh CR, Hsu I, Huang Q, Zhang X, Chang LS, Zuo L, Chen J, Doersch KM, Chang C, Yeh S. "Targeting newly identified ER?/TGF-?1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ER? selective antagonist in renal cell carcinoma." Molecular oncology.. 2018 Dec 0; 12(12):2055-2071. Epub 2018 Oct 30.

11/20/2018
Ou Z, Wang Y, Chen J, Tao L, Zuo L, Sahasrabudhe D, Joseph J, Wang L, Yeh S. "Estrogen receptor ? promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals." Experimental & molecular medicine.. 2018 Nov 20; 50(11):152. Epub 2018 Nov 20.

11/2018
Ou Z; Wang Y; Chen J; Tao L; Zuo L3; Sahasrabudhe D; Joseph J; Wang L; Yeh S. "Estrogen receptor ? promotes bladder cancer growth and invasion via alteration of miR-92a/DAB2IP signals." Exp Mol Med. 2018; .

11/2018
Bai J, Yeh S, Qiu X, Hu L, Zeng J, Cai Y, Zuo L, Li G, Yang G, Chang C. "TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals." Oncogene.. 2018 Nov 0; 37(44):5901-5912. Epub 2018 Jul 04.

10/3/2018
Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D. "A Festschrift in Honor of Edward M. Messing, MD, FACS." Bladder cancer.. 2018 Oct 3; 4(Suppl 1):S1-S43. Epub 2018 Oct 03.

9/24/2018
Yu W, Ding J, He M, Chen Y, Wang R, Han Z, Xing EZ, Zhang C, Yeh S. "Estrogen receptor ? promotes the vasculogenic mimicry (VM) and cell invasion via altering the lncRNA-MALAT1/miR-145-5p/NEDD9 signals in lung cancer." Oncogene.. 2018 Sep 24; Epub 2018 Sep 24.

9/21/2018
Luo J, Tian J, Chou F, Lin C, Xing EZ, Zuo L, Niu Y, Yeh S, Chang C. "Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9 led to increase docetaxel sensitivity via suppressing the p21 expression." Cancer letters.. 2018 Sep 21; Epub 2018 Sep 21.

9/2018
Ding J;, Yeh CR; Sun Y; Lin C; Chou J; Ou Z; Chang C; Qi J; Yeh S. "Estrogen receptor ? promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network." Oncogene. 2018; .

9/2018
Luo J; Tian J; Chou F; Lin C; Xing EZ; Zuo L; Niu Y; Yeh S; Chang C. "Targeting the androgen receptor (AR) with AR degradation enhancer ASC-J9® led to increase docetaxel sensitivity via suppressing the p21 expression." Cancer Letter. 2018; .

9/2018
Ding J, Yeh CR, Sun Y, Lin C, Chou J, Ou Z, Chang C, Qi J, Yeh S. "Estrogen receptor ? promotes renal cell carcinoma progression via regulating LncRNA HOTAIR-miR-138/200c/204/217 associated CeRNA network." Oncogene.. 2018 Sep 0; 37(37):5037-5053. Epub 2018 May 23.

8/28/2018
Tao L, Qiu J, Slavin S, Ou Z, Liu Z, Ge J, Guancial EA, Messing EM, Chang C, Yeh S. "Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor ?/IL-1/c-MET signals." Cancer letters.. 2018 Aug 28; 430:215-223. Epub 2018 Apr 22.

5/15/2018
Han Z, Zhang Y, Sun Y, Chen J, Chang C, Wang X, Yeh S. "ER?-Mediated Alteration of circATP2B1 and miR-204-3p Signaling Promotes Invasion of Clear Cell Renal Cell Carcinoma." Cancer research.. 2018 May 15; 78(10):2550-2563. Epub 2018 Feb 28.

3/28/2018
Cheng MA, Chou FJ, Wang K, Yang R, Ding J, Zhang Q, Li G, Yeh S, Xu D, Chang C. "Androgen receptor (AR) degradation enhancer ASC-J9 in an FDA-approved formulated solution suppresses castration resistant prostate cancer cell growth." Cancer letters.. 2018 Mar 28; 417:182-191. Epub 2018 Jan 17.

2018
Kao TL, Kuan YP, Cheng WC, Chang WC, Jeng LB, Yeh S, Ma WL. "Estrogen receptors orchestrate cell growth and differentiation to facilitate liver regeneration." Theranostics.. 2018 8(10):2672-2682. Epub 2018 Apr 09.

11/1/2017
Chen J, Li L, Yang Z, Luo J, Yeh S, Chang C. "Androgen-deprivation therapy with enzalutamide enhances prostate cancer metastasis via decreasing the EPHB6 suppressor expression." Cancer letters.. 2017 Nov 1; 408:155-163. Epub 2017 Aug 18.

11/2017
Wang R, Sun Y, Li L, Niu Y, Lin W, Lin C, Antonarakis ES, Luo J, Yeh S, Chang C. "Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9 to Suppress Enzalutamide-resistant Prostate Cancer Progression." European urology.. 2017 Nov 0; 72(5):835-844. Epub 2017 May 18.

11/2017
Kao TL, Chen YL, Kuan YP, Chang WC, Ho YC, Yeh S, Jeng LB, Ma WL. "Estrogen-Estrogen Receptor ? Signaling Facilitates Bilirubin Metabolism in Regenerating Liver Through Regulating Cytochrome P450 2A6 Expression." Cell transplantation.. 2017 Nov 0; 26(11):1822-1829.

7/10/2017
Lin SJ, Chou FJ, Li L, Lin CY, Yeh S, Chang C. "Natural killer cells suppress enzalutamide resistance and cell invasion in the castration resistant prostate cancer via targeting the androgen receptor splicing variant 7 (ARv7)." Cancer letters.. 2017 Jul 10; 398:62-69. Epub 2017 Mar 31.

7/1/2017
Guo C, Yeh S, Niu Y, Li G, Zheng J, Li L, Chang C. "Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer." Cancer letters.. 2017 Jul 1; 397:133-143. Epub 2017 Mar 18.

5/2017
Wang R; Sun Y; Li L; Niu Y; Lin W; Lin C; Antonarakis ES; Luo J; Yeh S; Chang C. "Preclinical Study using Malat1 Small Interfering RNA or Androgen Receptor Splicing Variant 7 Degradation Enhancer ASC-J9® to Suppress Enzalutamide-resistant Prostate Cancer Progression." Eur Urol. 2017; .

3/23/2017
Wang Y, Ou Z, Sun Y, Yeh S, Wang X, Long J, Chang C. "Androgen receptor promotes melanoma metastasis via altering the miRNA-539-3p/USP13/MITF/AXL signals." Oncogene.. 2017 Mar 23; 36(12):1644-1654. Epub 2016 Nov 21.

12/2016
Wen S, Niu Y, Lee SO, Yeh S, Shang Z, Gao H, Li Y, Chou F, Chang C. "Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells." Molecular carcinogenesis.. 2016 Dec 0; 55(12):2278-2290. Epub 2016 Feb 19.

12/2016
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J, Chang C. "Corrigendum to "Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11?miRNA-541?androgen receptor (AR)?MMP9 signaling" [Mol Oncol 9 (1) (2015) 44-57]." Molecular oncology.. 2016 Dec 0; 10(10):1628-1629. Epub 2016 Nov 04.

11/24/2016
Cui Y, Sun Y, Hu S, Luo J, Li L, Li X, Yeh S, Jin J, Chang C. "Neuroendocrine prostate cancer (NEPCa) increased the neighboring PCa chemoresistance via altering the PTHrP/p38/Hsp27/androgen receptor (AR)/p21 signals." Oncogene.. 2016 Nov 24; 35(47):6065-6076. Epub 2016 Jul 04.

10/11/2016
Lin SJ, Chou FJ, Lin CY, Chang HC, Yeh S, Chang C. "New therapy with ASC-J9® to suppress the prostatitis via altering the cytokine CCL2 signals." Oncotarget.. 2016 Oct 11; 7(41):66769-66775.

8/2016
Tao L, Qiu J, Jiang M, Song W, Yeh S, Yu H, Zang L, Xia S, Chang C. "Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1?Androgen Receptor?HIF1??VEGFa Signals." Molecular cancer therapeutics.. 2016 Aug 0; 15(8):1943-1951. Epub 2016 May 11.

7/1/2016
Wen S, Tian J, Niu Y, Li L, Yeh S, Chang C. "ASC-J9(®), and not Casodex or Enzalutamide, suppresses prostate cancer stem/progenitor cell invasion via altering the EZH2-STAT3 signals." Cancer letters.. 2016 Jul 1; 376(2):377-86. Epub 2016 Apr 01.

5/10/2016
Shang Z, Li Y, Hsu I, Zhang M, Tian J, Wen S, Han R, Messing EM, Chang C, Niu Y, Yeh S. "Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer." Oncotarget.. 2016 May 10; 7(19):27325-35.

5/2016
Shang Z; Li Y; Hsu I; Zhang M1, Tian J; Wen S;, Han R; Messing EM; Chang C; Niu Y; Yeh S. "Targeting estrogen/estrogen receptor alpha enhances Bacillus Calmette-Guérin efficacy in bladder cancer". Oncotarget. 2016; .

4/1/2016
Shi L, Lin H, Li G, Sun Y, Shen J, Xu J, Yeh S, Cai X, Chang C. "Cisplatin enhances NK cells immunotherapy efficacy to suppress HCC progression via altering the androgen receptor (AR)-ULBP2 signals." Cancer letters.. 2016 Apr 1; 373(1):45-56. Epub 2016 Jan 19.

4/2016
Shi L, Lin H, Li G, Jin RA, Xu J, Sun Y, Ma WL, Yeh S, Cai X, Chang C. "Targeting Androgen Receptor (AR)?IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression." Molecular cancer therapeutics.. 2016 Apr 0; 15(4):731-742. Epub 2016 Mar 03.

2/16/2016
Rao Q, Chen Y, Yeh CR, Jie D, Li L, Chang C, Yeh S. "Recruited mast cells in the tumor microenvironment enhance bladder cancer metastasis via modulation of ER?/CCL2/CCR2 EMT/MMP9 signals." Oncotarget.. 2016 Feb 16; 7(7):7842-55.

1/20/2016
Yeh CR, Slavin S, Da J, Hsu I, Luo J, Xiao GQ, Ding J, Chou FJ, Yeh S. "Estrogen receptor ? in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment." Molecular cancer.. 2016 Jan 20; 15:7. Epub 2016 Jan 20.

12/29/2015
Yeh CR, Ou ZY, Xiao GQ, Guancial E, Yeh S. "Infiltrating T cells promote renal cell carcinoma (RCC) progression via altering the estrogen receptor ?-DAB2IP signals." Oncotarget.. 2015 Dec 29; 6(42):44346-59.

12/15/2015
Lin C, Lin W, Yeh S, Li L, Chang C. "Infiltrating neutrophils increase bladder cancer cell invasion via modulation of androgen receptor (AR)/MMP13 signals." Oncotarget.. 2015 Dec 15; 6(40):43081-9.

11/1/2015
Song W, Li L, He D, Xie H, Chen J, Yeh CR, Chang LS, Yeh S, Chang C. "Infiltrating neutrophils promote renal cell carcinoma (RCC) proliferation via modulating androgen receptor (AR)???c-Myc signals." Cancer letters.. 2015 Nov 1; 368(1):71-78. Epub 2015 Jul 29.

11/2015
Shang Z, Li Y, Zhang M, Tian J, Han R, Shyr CR, Messing E, Yeh S, Niu Y, Chang C. "Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression." Molecular cancer therapeutics.. 2015 Nov 0; 14(11):2586-94. Epub 2015 Aug 11.

10/2015
Chen YH, Chen CJ, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Tsai KS, Wu SY, Chang C, Chen HY, Yeh S. "Proteomic analysis of urethral protein expression in an estrogen receptor ?-deficient murine model of stress urinary incontinence." World journal of urology.. 2015 Oct 0; 33(10):1635-43. Epub 2015 Jan 11.

9/22/2015
Ou Z, Wang Y, Liu L, Li L, Yeh S, Qi L, Chang C. "Tumor microenvironment B cells increase bladder cancer metastasis via modulation of the IL-8/androgen receptor (AR)/MMPs signals." Oncotarget.. 2015 Sep 22; 6(28):26065-78.

9/22/2015
Sha K, Yeh S, Chang C, Nastiuk KL, Krolewski JJ. "TNF signaling mediates an enzalutamide-induced metastatic phenotype of prostate cancer and microenvironment cell co-cultures." Oncotarget.. 2015 Sep 22; 6(28):25726-40.

9/21/2015
Singh S, Pan C, Wood R, Yeh CR, Yeh S, Sha K, Krolewski JJ, Nastiuk KL. "Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound." BMC urology. 2015 Sep 21; 15:97. Epub 2015 Sep 21.

8/7/2015
Song W, Yeh CR, He D, Wang Y, Xie H, Pang ST, Chang LS, Li L, Yeh S. "Infiltrating neutrophils promote renal cell carcinoma progression via VEGFa/HIF2? and estrogen receptor ? signals." Oncotarget.. 2015 Aug 7; 6(22):19290-304.

8/2015
Dang Q, Li L, Xie H, He D, Chen J, Song W, Chang LS, Chang HC, Yeh S, Chang C. "Anti-androgen enzalutamide enhances prostate cancer neuroendocrine (NE) differentiation via altering the infiltrated mast cells ? androgen receptor (AR) ? miRNA32 signals." Molecular oncology.. 2015 Aug 0; 9(7):1241-51. Epub 2015 Mar 05.

8/2015
Wen S, Niu Y, Yeh S, Chang C. "BM-MSCs promote prostate cancer progression via the conversion of normal fibroblasts to cancer-associated fibroblasts." International journal of oncology.. 2015 Aug 0; 47(2):719-27. Epub 2015 Jun 22.

6/10/2015
Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C. "Infiltrating mast cells enhance prostate cancer invasion via altering LncRNA-HOTAIR/PRC2-androgen receptor (AR)-MMP9 signals and increased stem/progenitor cell population." Oncotarget.. 2015 Jun 10; 6(16):14179-90.

5/20/2015
Xie H, Li L, Zhu G, Dang Q, Ma Z, He D, Chang L, Song W, Chang HC, Krolewski JJ, Nastiuk KL, Yeh S, Chang C. "Infiltrated pre-adipocytes increase prostate cancer metastasis via modulation of the miR-301a/androgen receptor (AR)/TGF-?1/Smad/MMP9 signals." Oncotarget.. 2015 May 20; 6(14):12326-39.

4/30/2015
Wang RS, Chang HY, Kao SH, Kao CH, Wu YC, Yeh S, Tzeng CR, Chang C. "Abnormal mitochondrial function and impaired granulosa cell differentiation in androgen receptor knockout mice." International journal of molecular sciences.. 2015 Apr 30; 16(5):9831-49. Epub 2015 Apr 30.

1/2015
Hu S, Li L, Yeh S, Cui Y, Li X, Chang HC, Jin J, Chang C. "Infiltrating T cells promote prostate cancer metastasis via modulation of FGF11?miRNA-541?androgen receptor (AR)?MMP9 signaling." Molecular oncology.. 2015 Jan 0; 9(1):44-57. Epub 2014 Jul 29.

2015
Yeh CR, Hsu I, Song W, Chang H, Miyamoto H, Xiao GQ, Li L, Yeh S. "Fibroblast ER? promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment." American journal of cancer research.. 2015 5(3):1146-57. Epub 2015 Feb 15.

2015
Wang X, Ring BZ, Seitz RS, Ross DT, Woolf K, Beck RA, Hicks DG, Yeh S. "Expression of a-Tocopherol-Associated protein (TAP) is associated with clinical outcome in breast cancer patients." BMC clinical pathology. 2015 15:21. Epub 2015 Dec 09.

10/2014
Wu S, Chen Y, Fajobi T, DiVall SA, Chang C, Yeh S, Wolfe A. "Conditional knockout of the androgen receptor in gonadotropes reveals crucial roles for androgen in gonadotropin synthesis and surge in female mice." Molecular endocrinology.. 2014 Oct 0; 28(10):1670-81. Epub 2014 Aug 26.

10/2014
Yu IC, Lin HY, Sparks JD, Yeh S, Chang C. "Androgen receptor roles in insulin resistance and obesity in males: the linkage of androgen-deprivation therapy to metabolic syndrome." Diabetes.. 2014 Oct 0; 63(10):3180-8.

9/15/2014
Hsu I, Yeh CR, Slavin S, Miyamoto H, Netto GJ, Tsai YC, Muyan M, Wu XR, Messing EM, Guancial EA, Yeh S. "Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo." Oncotarget.. 2014 Sep 15; 5(17):7917-35.

8/15/2014
He D, Li L, Zhu G, Liang L, Guan Z, Chen Y, Yeh S, Chang C. "ASC-J9 suppresses renal cell carcinoma progression by targeting an androgen receptor-dependent HIF2?/VEGF signaling pathway." Cancer research.. 2014 Aug 15; 74(16):4420-30. Epub 2014 Jun 12.

8/2014
Liang L, Li L, Tian J, Lee SO, Dang Q, Huang CK, Yeh S, Erturk E, Bushinsky D, Chang LS, He D, Chang C. "Androgen receptor enhances kidney stone-CaOx crystal formation via modulation of oxalate biosynthesis & oxidative stress." Molecular endocrinology.. 2014 Aug 0; 28(8):1291-303. Epub 2014 Jun 23.

6/19/2014
Chang C, Lee SO, Yeh S, Chang TM. "Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver." Oncogene.. 2014 Jun 19; 33(25):3225-34. Epub 2013 Jul 22.

6/2014
Slavin S, Yeh CR, Jun D, Yu S, Miyamoto H, Messing EM, Yeh S. "Estrogen receptor ? in cancer-associated fibroblasts suppresses prostate cancer invasion via modulation of thrombospondin 2 and matrix metalloproteinase 3." Carcinogenesis.. 2014 Jun 0; 35(6):1301-9. Epub 2013 Dec 28.

6/2014
Ma WL, Lai HC, Yeh S, Cai X, Chang C. "Androgen receptor roles in hepatocellular carcinoma, fatty liver, cirrhosis and hepatitis." Endocrine-related cancer.. 2014 Jun 0; 21(3):R165-82. Epub 2014 May 06.

3/2014
Shang Z; Niu Y; Cai Q; Chen J;, Tian J; Yeh S; Lai KP; Chang C. "Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation." Tumour Biol. 2014; .

3/2014
Hsu I, Chuang KL, Slavin S, da J, Lim WX, Pang ST, O'Brien JH, Yeh S. "Suppression of ER? signaling via ER? knockout or antagonist protects against bladder cancer development." Carcinogenesis.. 2014 Mar 0; 35(3):651-61. Epub 2013 Oct 22.

2/2014
Zhu G, Liang L, Li L, Dang Q, Song W, Yeh S, He D, Chang C. "The expression and evaluation of androgen receptor in human renal cell carcinoma." Urology.. 2014 Feb 0; 83(2):510.e19-24. Epub 2013 Dec 12.

1/2014
Guancial EA, Bellmunt J, Yeh S, Rosenberg JE, Berman DM. "The evolving understanding of microRNA in bladder cancer." Urologic oncology.. 2014 Jan 0; 32(1):41.e31-40. Epub 2013 Aug 02.

1/2014
Soh SF, Huang CK, Lee SO, Xu D, Yeh S, Li J, Yong EL, Gong Y, Chang C. "Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometry." Journal of pharmaceutical and biomedical analysis.. 2014 Jan 0; 88:117-22. Epub 2013 Aug 27.

2014
Xu D, Lin TH, Yeh CR, Cheng MA, Chen LM, Chang C, Yeh S. "The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth." BioMed research international.. 2014 2014:713263. Epub 2014 Aug 13.

2014
Chen YH, Chen CJ, Yeh S, Lin YN, Wu YC, Hsieh WT, Wu BT, Ma WL, Chen WC, Chang C, Chen HY. "Urethral dysfunction in female mice with estrogen receptor ? deficiency." PloS one.. 2014 9(9):e109058. Epub 2014 Oct 02.

2014
Yeh CR, Da J, Song W, Fazili A, Yeh S. "Estrogen receptors in prostate development and cancer." American journal of clinical and experimental urology.. 2014 2(2):161-8. Epub 2014 Jul 12.

10/2013
Lai KP, Huang CK, Fang LY, Izumi K, Lo CW, Wood R, Kindblom J, Yeh S, Chang C. "Targeting stromal androgen receptor suppresses prolactin-driven benign prostatic hyperplasia (BPH)." Molecular endocrinology.. 2013 Oct 0; 27(10):1617-31. Epub 2013 Jul 26.

8/8/2013
Lin TH, Izumi K, Lee SO, Lin WJ, Yeh S, Chang C. "Anti-androgen receptor ASC-J9 versus anti-androgens MDV3100 (Enzalutamide) or Casodex (Bicalutamide) leads to opposite effects on prostate cancer metastasis via differential modulation of macrophage infiltration and STAT3-CCL2 signaling." Cell death & disease.. 2013 Aug 8; 4:e764. Epub 2013 Aug 08.

8/2013
Yu S; Xia ; Yang D; Wang K;Yeh S; Gao Z; Chang C. "Androgen receptor in human prostate cancer-associated fibroblasts promotes prostate cancer epithelial cell growth and invasion." Medical Oncology. 2013; .

8/2013
Soh SF;Huang C; Lee SO; Xu D; Yeh S; Li J; Yong EL; Gong Y; Chang C. "Determination of androgen receptor degradation enhancer ASC-J9(®) in mouse sera and organs with liquid chromatography tandem mass spectrometry." J Pharm Biomed Anal. 2013; .

7/5/2013
Lin TH, Lee SO, Niu Y, Xu D, Liang L, Li L, Yeh SD, Fujimoto N, Yeh S, Chang C. "Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis." The Journal of biological chemistry.. 2013 Jul 5; 288(27):19359-69. Epub 2013 May 16.

7/2013
Chang C; Lee SO; Wang RS; Yeh S; Chang TM. "Androgen receptor (AR) physiological roles in male and female reproductive systems: lessons learned from AR-knockout mice lacking AR in selective cells." Biology of Reproduction. 2013; .

7/2013
Chang C, Lee SO, Wang RS, Yeh S, Chang TM. "Androgen receptor (AR) physiological roles in male and female reproductive systems: lessons learned from AR-knockout mice lacking AR in selective cells." Biology of reproduction.. 2013 Jul 0; 89(1):21. Epub 2013 Jul 25.

6/2013
Wang X, Lee SO, Xia S, Jiang Q, Luo J, Li L, Yeh S, Chang C. "Endothelial cells enhance prostate cancer metastasis via IL-6?androgen receptor?TGF-??MMP-9 signals." Molecular cancer therapeutics.. 2013 Jun 0; 12(6):1026-37. Epub 2013 Mar 27.

6/2013
Hsu I, Vitkus S, Da J, Yeh S. "Role of oestrogen receptors in bladder cancer development." Nature reviews. Urology.. 2013 Jun 0; 10(6):317-26. Epub 2013 Apr 16.

2/2013
Shyr CR; Chen CC; Hsieh TF; Chang CH; Ma WL; Yeh S; Messing E; Li TH; Li FY; Chang C. "The expression and actions of androgen receptor in upper urinary tract urothelial carcinoma (UUTUC) tissues and the primary cultured cells". Endocrine. 2013; .

2/2013
Li L; Xie H; Liang ; Gao Y; Zhang D; Fang L; Lee SO; Luo J; Chen X; Wang X; Chang LS; Yeh S; Wang Y; He D; Chang C. "Increased PrLZ-mediated androgen receptor transactivation promotes prostate cancer growth at castration-resistant stage". Carcinogenesis. 2013; .

2/2013
Lee SO, Ma Z, Yeh CR, Luo J, Lin TH, Lai KP, Yamashita S, Liang L, Tian J, Li L, Jiang Q, Huang CK, Niu Y, Yeh S, Chang C. "New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells." Journal of molecular cell biology. 2013 Feb 0; 5(1):14-26. Epub 2012 Jul 24.

2/2013
Yu IC, Lin HY, Liu NC, Sparks JD, Yeh S, Fang LY, Chen L, Chang C. "Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-?B-mediated PTP1B expression." Diabetes.. 2013 Feb 0; 62(2):411-23. Epub 2012 Nov 08.

2/2013
Lai KP, Huang CK, Chang YJ, Chung CY, Yamashita S, Li L, Lee SO, Yeh S, Chang C. "New therapeutic approach to suppress castration-resistant prostate cancer using ASC-J9 via targeting androgen receptor in selective prostate cells." The American journal of pathology.. 2013 Feb 0; 182(2):460-73. Epub 2012 Dec 04.

1/2013
Vitkus S, Yeh CR, Lin HH, Hsu I, Yu J, Chen M, Yeh S. "Distinct function of estrogen receptor ? in smooth muscle and fibroblast cells in prostate development." Molecular endocrinology.. 2013 Jan 0; 27(1):38-49. Epub 2012 Nov 30.

1/2013
Lai KP, Lai JJ, Chang P, Altuwaijri S, Hsu JW, Chuang KH, Shyr CR, Yeh S, Chang C. "Targeting thymic epithelia AR enhances T-cell reconstitution and bone marrow transplant grafting efficacy." Molecular endocrinology.. 2013 Jan 0; 27(1):25-37. Epub 2012 Dec 18.

2013
Chang C, Yeh S, Lee SO, Chang TM. "Androgen receptor (AR) pathophysiological roles in androgen-related diseases in skin, bone/muscle, metabolic syndrome and neuron/immune systems: lessons learned from mice lacking AR in specific cells." Nuclear receptor signaling. 2013 11:e001. Epub 2013 Aug 19.

10/2012
Jiang Q, Yeh S, Wang X, Xu D, Zhang Q, Wen X, Xia S, Chang C. "Targeting androgen receptor leads to suppression of prostate cancer via induction of autophagy." The Journal of urology.. 2012 Oct 0; 188(4):1361-8. Epub 2012 Aug 17.

8/2012
Lai KP, Yamashita S, Huang CK, Yeh S, Chang C. "Loss of stromal androgen receptor leads to suppressed prostate tumourigenesis via modulation of pro-inflammatory cytokines/chemokines." EMBO molecular medicine.. 2012 Aug 0; 4(8):791-807. Epub 2012 Jun 29.

7/2012
Ma WL, Hsu CL, Yeh CC, Wu MH, Huang CK, Jeng LB, Hung YC, Lin TY, Yeh S, Chang C. "Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis." Hepatology : official journal of the American Association for the Study of Liver Diseases.. 2012 Jul 0; 56(1):176-85. Epub 2012 Jun 05.

7/2012
Chen M, Yeh CR, Shyr CR, Lin HH, Da J, Yeh S. "Reduced prostate branching morphogenesis in stromal fibroblast, but not in epithelial, estrogen receptor ? knockout mice." Asian journal of andrology.. 2012 Jul 0; 14(4):546-55. Epub 2012 May 21.

6/2012
Miyamoto H, Yao JL, Chaux A, Zheng Y, Hsu I, Izumi K, Chang C, Messing EM, Netto GJ, Yeh S. "Expression of androgen and oestrogen receptors and its prognostic significance in urothelial neoplasm of the urinary bladder." BJU international.. 2012 Jun 0; 109(11):1716-26. Epub 2012 Jan 05.

5/15/2012
Xu D, Lin TH, Zhang C, Tsai YC, Li S, Zhang J, Yin M, Yeh S, Chang C. "The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells." The Prostate.. 2012 May 15; 72(7):803-16. Epub 2011 Sep 19.

5/2012
Lee SO1, Tian J, Huang CK, Ma Z, Lai KP, Hsiao H, Jiang M, Yeh S, Chang C. "Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells." Journal of Endocrinology. 2012; .

5/2012
Lee SO, Tian J, Huang CK, Ma Z, Lai KP, Hsiao H, Jiang M, Yeh S, Chang C. "Suppressor role of androgen receptor in proliferation of prostate basal epithelial and progenitor cells." The Journal of endocrinology.. 2012 May 0; 213(2):173-82. Epub 2012 Mar 05.

3/2012
Yu S, Yeh CR, Niu Y, Chang HC, Tsai YC, Moses HL, Shyr CR, Chang C, Yeh S. "Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts." The Prostate.. 2012 Mar 0; 72(4):437-49. Epub 2011 Jul 07.

3/2012
Xu D, Lin TH, Li S, Da J, Wen XQ, Ding J, Chang C, Yeh S. "Cryptotanshinone suppresses androgen receptor-mediated growth in androgen dependent and castration resistant prostate cancer cells." Cancer letters.. 2012 Mar 0; 316(1):11-22. Epub 2011 Oct 10.

1/2012
Lai KP;, Yamashita S; Vitkus S; Shyr CR; Yeh S; Chang C. "Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor." Mol Endocrinol. 2012; .

1/2012
Chen M, Yeh CR, Chang HC, Vitkus S, Wen XQ, Bhowmick NA, Wolfe A, Yeh S. "Loss of epithelial oestrogen receptor ? inhibits oestrogen-stimulated prostate proliferation and squamous metaplasia via in vivo tissue selective knockout models." The Journal of pathology.. 2012 Jan 0; 226(1):17-27. Epub 2011 Nov 09.

1/2012
Lai KP, Yamashita S, Vitkus S, Shyr CR, Yeh S, Chang C. "Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor." Molecular endocrinology.. 2012 Jan 0; 26(1):52-66. Epub 2011 Dec 01.

1/2012
Yamashita S, Lai KP, Chuang KL, Xu D, Miyamoto H, Tochigi T, Pang ST, Li L, Arai Y, Kung HJ, Yeh S, Chang C. "ASC-J9 suppresses castration-resistant prostate cancer growth through degradation of full-length and splice variant androgen receptors." Neoplasia : an international journal for oncology research.. 2012 Jan 0; 14(1):74-83.

2012
Cao W, Ma Z, Rasenick MM, Yeh S, Yu J. "N-3 poly-unsaturated fatty acids shift estrogen signaling to inhibit human breast cancer cell growth." PloS one.. 2012 7(12):e52838. Epub 2012 Dec 28.

7/2011
Niu Y; Wang J; Shang Z; Huang SP; Shyr CR; Yeh S; Chang C. "Increased CK5/CK8-positive intermediate cells with stromal smooth muscle cell atrophy in the mice lacking prostate epithelial androgen receptor." PLoS One. 2011; .

4/2011
Yu S, Zhang C, Lin CC, Niu Y, Lai KP, Chang HC, Yeh SD, Chang C, Yeh S. "Altered prostate epithelial development and IGF-1 signal in mice lacking the androgen receptor in stromal smooth muscle cells." The Prostate.. 2011 Apr 0; 71(5):517-24. Epub 2010 Oct 13.

2011
Lin TH, Yeh S, Chang C. "Tissue-specific knockout of androgen receptor in mice." Methods in molecular biology.. 2011 776:275-93.

6/24/2010
Niu Y, Chang TM, Yeh S, Ma WL, Wang YZ, Chang C. "Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails." Oncogene.. 2010 Jun 24; 29(25):3593-604. Epub 2010 May 03.

5/2010
Wu MH; Ma WL; Hsu CL; Chen YL; Ou JH; Ryan CK; Hung YC; Yeh S; Chang C. "Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription." Sci Transl Med. 2010; .

2/1/2010
Shyr CR, Tsai MY, Yeh S, Kang HY, Chang YC, Wong PL, Huang CC, Huang KE, Chang C. "Tumor suppressor PAX6 functions as androgen receptor co-repressor to inhibit prostate cancer growth." The Prostate.. 2010 Feb 1; 70(2):190-9.

6/22/2009
Wang X, Ni J, Hsu CL, Johnykutty S, Tang P, Ho YS, Lee CH, Yeh S. "Reduced Expression of Tocopherol-Associated Protein (TAP/Sec14L2) in Human Breast Cancer." Cancer investigation.. 2009 Jun 22; :1. Epub 2009 Jun 22.

6/2009
Johnykutty S, Tang P, Zhao H, Hicks DG, Yeh S, Wang X. "Dual expression of alpha-tocopherol-associated protein and estrogen receptor in normal/benign human breast luminal cells and the downregulation of alpha-tocopherol-associated protein in estrogen-receptor-positive breast carcinomas." Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.. 2009 Jun 0; 22(6):770-5. Epub 2009 Mar 20.

5/29/2009
Nott SL, Huang Y, Li X, Fluharty BR, Qiu X, Welshons WV, Yeh S, Muyan M. "Genomic responses from the estrogen-responsive element-dependent signaling pathway mediated by estrogen receptor alpha are required to elicit cellular alterations." The Journal of biological chemistry.. 2009 May 29; 284(22):15277-88. Epub 2009 Mar 24.

5/2009
Chen M, Ni J, Chang HC, Lin CY, Muyan M, Yeh S. "CCDC62/ERAP75 functions as a coactivator to enhance estrogen receptor beta-mediated transactivation and target gene expression in prostate cancer cells." Carcinogenesis.. 2009 May 0; 30(5):841-50. Epub 2009 Jan 06.

4/2009
Altuwaijri S, Chuang KH, Lai KP, Lai JJ, Lin HY, Young FM, Bottaro A, Tsai MY, Zeng WP, Chang HC, Yeh S, Chang C. "Susceptibility to autoimmunity and B cell resistance to apoptosis in mice lacking androgen receptor in B cells." Molecular endocrinology.. 2009 Apr 0; 23(4):444-53. Epub 2009 Jan 22.

4/2009
Wang RS, Yeh S, Tzeng CR, Chang C. "Androgen receptor roles in spermatogenesis and fertility: lessons from testicular cell-specific androgen receptor knockout mice." Endocrine reviews.. 2009 Apr 0; 30(2):119-32. Epub 2009 Jan 27.

2/1/2009
Ni J, Mai T, Pang ST, Haque I, Huang K, DiMaggio MA, Xie S, James NS, Kasi D, Chemler SR, Yeh S. "In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2009 Feb 1; 15(3):898-906.

1/1/2009
Yin Y, Ni J, Chen M, Guo Y, Yeh S. "RRR-alpha-vitamin E succinate potentiates the antitumor effect of calcitriol in prostate cancer without overt side effects." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2009 Jan 1; 15(1):190-200.

1/2009
Yu SQ; Lai KP; Xia SJ; Chang HC; Chang C; Yeh S. "The diverse and contrasting effects of using human prostate cancer cell lines to study androgen receptor roles in prostate cancer". Asian J Androl. 2009; .

1/2009
Chen M, Hsu I, Wolfe A, Radovick S, Huang K, Yu S, Chang C, Messing EM, Yeh S. "Defects of prostate development and reproductive system in the estrogen receptor-alpha null male mice." Endocrinology.. 2009 Jan 0; 150(1):251-9. Epub 2008 Aug 28.

1/2009
Chen M, Wolfe A, Wang X, Chang C, Yeh S, Radovick S. "Generation and characterization of a complete null estrogen receptor alpha mouse using Cre/LoxP technology." Molecular and cellular biochemistry.. 2009 Jan 0; 321(1-2):145-53. Epub 2008 Oct 25.

9/1/2008
Chen M, Ni J, Zhang Y, Muyan M, Yeh S. "ERAP75 functions as a coactivator to enhance estrogen receptor alpha transactivation in prostate stromal cells." The Prostate.. 2008 Sep 1; 68(12):1273-82.

9/1/2008
Niu Y, Yeh S, Miyamoto H, Li G, Altuwaijri S, Yuan J, Han R, Ma T, Kuo HC, Chang C. "Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation." Cancer research.. 2008 Sep 1; 68(17):7110-9.

9/2008
Ma WL, Ma CL, Hsu CL, Wu MH, Wu CT, Wu CC, Lai JJ, Jou YS, Chen CW, Yeh S, Chang C. "Androgen receptor is a new potential therapeutic target for the treatment of hepatocellular carcinoma." Gastroenterology.. 2008 Sep 0; 135(3):947-55, 955.e1-5. Epub 2008 May 22.

8/26/2008
Niu Y, Altuwaijri S, Yeh S, Lai KP, Yu S, Chuang KH, Huang SP, Lardy H, Chang C. "Targeting the stromal androgen receptor in primary prostate tumors at earlier stages." Proceedings of the National Academy of Sciences of the United States of America.. 2008 Aug 26; 105(34):12188-93. Epub 2008 Aug 22.

8/26/2008
Niu Y, Altuwaijri S, Lai KP, Wu CT, Ricke WA, Messing EM, Yao J, Yeh S, Chang C. "Androgen receptor is a tumor suppressor and proliferator in prostate cancer." Proceedings of the National Academy of Sciences of the United States of America.. 2008 Aug 26; 105(34):12182-7. Epub 2008 Aug 22.

6/2008
Lin HY, Yu IC, Wang RS, Chen YT, Liu NC, Altuwaijri S, Hsu CL, Ma WL, Jokinen J, Sparks JD, Yeh S, Chang C. "Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptor." Hepatology : official journal of the American Association for the Study of Liver Diseases.. 2008 Jun 0; 47(6):1924-35.

5/2008
Yu IC, Lin HY, Liu NC, Wang RS, Sparks JD, Yeh S, Chang C. "Hyperleptinemia without obesity in male mice lacking androgen receptor in adipose tissue." Endocrinology.. 2008 May 0; 149(5):2361-8. Epub 2008 Feb 14.

8/2007
Xu Q, Lin HY, Yeh SD, Yu IC, Wang RS, Chen YT, Zhang C, Altuwaijri S, Chen LM, Chuang KH, Chiang HS, Yeh S, Chang C. "Infertility with defective spermatogenesis and steroidogenesis in male mice lacking androgen receptor in Leydig cells." Endocrine.. 2007 Aug 0; 32(1):96-106. Epub 2007 Oct 23.

7/31/2007
Wu CT, Altuwaijri S, Ricke WA, Huang SP, Yeh S, Zhang C, Niu Y, Tsai MY, Chang C. "Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor." Proceedings of the National Academy of Sciences of the United States of America.. 2007 Jul 31; 104(31):12679-84. Epub 2007 Jul 25.

4/4/2007
Miyamoto H, Yang Z, Chen YT, Ishiguro H, Uemura H, Kubota Y, Nagashima Y, Chang YJ, Hu YC, Tsai MY, Yeh S, Messing EM, Chang C. "Promotion of bladder cancer development and progression by androgen receptor signals." Journal of the National Cancer Institute.. 2007 Apr 4; 99(7):558-68.

4/1/2007
Ni J, Pang ST, Yeh S. "Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells." The Prostate.. 2007 Apr 1; 67(5):463-71.

4/1/2007
Yin Y, Ni J, Chen M, DiMaggio MA, Guo Y, Yeh S. "The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2007 Apr 1; 13(7):2271-80.

3/2007
Yang Z, Chang YJ, Miyamoto H, Yeh S, Yao JL, di Sant'Agnese PA, Tsai MY, Chang C. "Suppression of androgen receptor transactivation and prostate cancer cell growth by heterogeneous nuclear ribonucleoprotein A1 via interaction with androgen receptor coregulator ARA54." Endocrinology.. 2007 Mar 0; 148(3):1340-9. Epub 2006 Nov 16.

3/2007
Yang Z, Chang YJ, Yu IC, Yeh S, Wu CC, Miyamoto H, Merry DE, Sobue G, Chen LM, Chang SS, Chang C. "ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor." Nature medicine.. 2007 Mar 0; 13(3):348-53. Epub 2007 Mar 04.

1/2007
Chang E, Ni J, Yin Y, Lin CC, Chang P, James NS, Chemler SR, Yeh S. "Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells." Asian journal of andrology.. 2007 Jan 0; 9(1):31-9.

2007
Ni J, Yeh S. "The roles of alpha-vitamin E and its analogues in prostate cancer." Vitamins and hormones.. 2007 76:493-518.

12/12/2006
Tsai MY, Yeh SD, Wang RS, Yeh S, Zhang C, Lin HY, Tzeng CR, Chang C. "Differential effects of spermatogenesis and fertility in mice lacking androgen receptor in individual testis cells." Proceedings of the National Academy of Sciences of the United States of America.. 2006 Dec 12; 103(50):18975-80. Epub 2006 Dec 01.

12/2006
Wang RS, Yeh S, Chen LM, Lin HY, Zhang C, Ni J, Wu CC, di Sant'Agnese PA, deMesy-Bentley KL, Tzeng CR, Chang C. "Androgen receptor in sertoli cell is essential for germ cell nursery and junctional complex formation in mouse testes." Endocrinology.. 2006 Dec 0; 147(12):5624-33. Epub 2006 Sep 14.

11/21/2006
Zhang C, Yeh S, Chen YT, Wu CC, Chuang KH, Lin HY, Wang RS, Chang YJ, Mendis-Handagama C, Hu L, Lardy H, Chang C. "Oligozoospermia with normal fertility in male mice lacking the androgen receptor in testis peritubular myoid cells." Proceedings of the National Academy of Sciences of the United States of America.. 2006 Nov 21; 103(47):17718-23. Epub 2006 Nov 09.

11/1/2005
Ni J, Wen X, Yao J, Chang HC, Yin Y, Zhang M, Xie S, Chen M, Simons B, Chang P, di Sant'Agnese A, Messing EM, Yeh S. "Tocopherol-associated protein suppresses prostate cancer cell growth by inhibition of the phosphoinositide 3-kinase pathway." Cancer research.. 2005 Nov 1; 65(21):9807-16.

6/2005
Cai G; Huang H; Shapiro ; Zhou H; Yeh S; Melamed J; Greco MA; Lee P. "Expression of androgen receptor associated protein 55 (ARA55) in the developing human fetal prostate." Journal of Urology. 2005; .

6/2005
Lin HY, Xu Q, Yeh S, Wang RS, Sparks JD, Chang C. "Insulin and leptin resistance with hyperleptinemia in mice lacking androgen receptor." Diabetes.. 2005 Jun 0; 54(6):1717-25.

3/2005
Li R, Ni J, Bourne PA, Yeh S, Yao J, di Sant'Agnese PA, Huang J. "Cell culture block array for immunocytochemical study of protein expression in cultured cells." Applied immunohistochemistry & molecular morphology : AIMM. 2005 Mar 0; 13(1):85-90.

2/2005
Hsu CL, Chen YL, Ting HJ, Lin WJ, Yang Z, Zhang Y, Wang L, Wu CT, Chang HC, Yeh S, Pimplikar SW, Chang C. "Androgen receptor (AR) NH2- and COOH-terminal interactions result in the differential influences on the AR-mediated transactivation and cell growth." Molecular endocrinology.. 2005 Feb 0; 19(2):350-61. Epub 2004 Oct 28.

11/2004
Wu Y; Zu K; Ni J; Yeh S; Kasi D; James NS; Chemler S; Ip C. "Cellular and molecular effects of alpha-tocopheryloxybutyrate: lessons for the design of vitamin E analog for cancer prevention". Anticancer Research. 2004; .

10/2004
Altuwaijri S, Lee DK, Chuang KH, Ting HJ, Yang Z, Xu Q, Tsai MY, Yeh S, Hanchett LA, Chang HC, Chang C. "Androgen receptor regulates expression of skeletal muscle-specific proteins and muscle cell types." Endocrine.. 2004 Oct 0; 25(1):27-32.

8/6/2004
Hu YC, Yeh S, Yeh SD, Sampson ER, Huang J, Li P, Hsu CL, Ting HJ, Lin HK, Wang L, Kim E, Ni J, Chang C. "Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer." The Journal of biological chemistry.. 2004 Aug 6; 279(32):33438-46. Epub 2004 May 27.

8/3/2004
Hu YC, Wang PH, Yeh S, Wang RS, Xie C, Xu Q, Zhou X, Chao HT, Tsai MY, Chang C. "Subfertility and defective folliculogenesis in female mice lacking androgen receptor." Proceedings of the National Academy of Sciences of the United States of America.. 2004 Aug 3; 101(31):11209-14. Epub 2004 Jul 26.

5/4/2004
Chang C, Chen YT, Yeh SD, Xu Q, Wang RS, Guillou F, Lardy H, Yeh S. "Infertility with defective spermatogenesis and hypotestosteronemia in male mice lacking the androgen receptor in Sertoli cells." Proceedings of the National Academy of Sciences of the United States of America.. 2004 May 4; 101(18):6876-81. Epub 2004 Apr 23.

4/15/2004
Zhang M, Altuwaijri S, Yeh S. "RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness." Oncogene.. 2004 Apr 15; 23(17):3080-8.

3/2004
Wang L, Hsu CL, Ni J, Wang PH, Yeh S, Keng P, Chang C. "Human checkpoint protein hRad9 functions as a negative coregulator to repress androgen receptor transactivation in prostate cancer cells." Molecular and cellular biology.. 2004 Mar 0; 24(5):2202-13.

2/2004
Zhang Y, Yang Y, Yeh S, Chang C. "ARA67/PAT1 functions as a repressor to suppress androgen receptor transactivation." Molecular and cellular biology.. 2004 Feb 0; 24(3):1044-57.

12/15/2003
Yeh S, Hu YC, Wang PH, Xie C, Xu Q, Tsai MY, Dong Z, Wang RS, Lee TH, Chang C. "Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor." The Journal of experimental medicine.. 2003 Dec 15; 198(12):1899-908.

11/1/2003
Altuwaijri S, Lin HK, Chuang KH, Lin WJ, Yeh S, Hanchett LA, Rahman MM, Kang HY, Tsai MY, Zhang Y, Yang L, Chang C. "Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells." Cancer research.. 2003 Nov 1; 63(21):7106-12.

8/15/2003
Nishimura K, Ting HJ, Harada Y, Tokizane T, Nonomura N, Kang HY, Chang HC, Yeh S, Miyamoto H, Shin M, Aozasa K, Okuyama A, Chang C. "Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator." Cancer research.. 2003 Aug 15; 63(16):4888-94.

6/27/2003
Hsu CL, Chen YL, Yeh S, Ting HJ, Hu YC, Lin H, Wang X, Chang C. "The use of phage display technique for the isolation of androgen receptor interacting peptides with (F/W)XXL(F/W) and FXXLY new signature motifs." The Journal of biological chemistry.. 2003 Jun 27; 278(26):23691-8. Epub 2003 Apr 24.

5/30/2003
Rahman MM, Miyamoto H, Takatera H, Yeh S, Altuwaijri S, Chang C. "Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells." The Journal of biological chemistry.. 2003 May 30; 278(22):19619-26. Epub 2003 Mar 20.

1/10/2003
Ni J, Chen M, Zhang Y, Li R, Huang J, Yeh S. "Vitamin E succinate inhibits human prostate cancer cell growth via modulating cell cycle regulatory machinery." Biochemical and biophysical research communications.. 2003 Jan 10; 300(2):357-63.

2003
Collins LL, Lee HJ, Chen YT, Chang M, Hsu HY, Yeh S, Chang C. "The androgen receptor in spermatogenesis." Cytogenetic and genome research.. 2003 103(3-4):299-301.

10/15/2002
Yeh S, Tsai MY, Xu Q, Mu XM, Lardy H, Huang KE, Lin H, Yeh SD, Altuwaijri S, Zhou X, Xing L, Boyce BF, Hung MC, Zhang S, Gan L, Chang C, Hung MC. "Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues." Proceedings of the National Academy of Sciences of the United States of America.. 2002 Oct 15; 99(21):13498-503. Epub 2002 Oct 07.

9/27/2002
Thin TH, Kim E, Yeh S, Sampson ER, Chen YT, Collins LL, Basavappa R, Chang C. "Mutations in the helix 3 region of the androgen receptor abrogate ARA70 promotion of 17beta-estradiol-induced androgen receptor transactivation." The Journal of biological chemistry.. 2002 Sep 27; 277(39):36499-508. Epub 2002 Jun 14.

5/28/2002
Zhang Y, Ni J, Messing EM, Chang E, Yang CR, Yeh S. "Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 2002 May 28; 99(11):7408-13.

5/3/2002
Wang X, Yang Y, Guo X, Sampson ER, Hsu CL, Tsai MY, Yeh S, Wu G, Guo Y, Chang C. "Suppression of androgen receptor transactivation by Pyk2 via interaction and phosphorylation of the ARA55 coregulator." The Journal of biological chemistry.. 2002 May 3; 277(18):15426-31. Epub 2002 Feb 20.

2/15/2002
Miyamoto H, Rahman M, Takatera H, Kang HY, Yeh S, Chang HC, Nishimura K, Fujimoto N, Chang C. "A dominant-negative mutant of androgen receptor coregulator ARA54 inhibits androgen receptor-mediated prostate cancer growth." The Journal of biological chemistry.. 2002 Feb 15; 277(7):4609-17. Epub 2001 Oct 22.

1/22/2002
Ting HJ, Yeh S, Nishimura K, Chang C. "Supervillin associates with androgen receptor and modulates its transcriptional activity." Proceedings of the National Academy of Sciences of the United States of America.. 2002 Jan 22; 99(2):661-6. Epub 2002 Jan 15.

11/2/2001
Wang X, Yeh S, Wu G, Hsu CL, Wang L, Chiang T, Yang Y, Guo Y, Chang C. "Identification and characterization of a novel androgen receptor coregulator ARA267-alpha in prostate cancer cells." The Journal of biological chemistry.. 2001 Nov 2; 276(44):40417-23. Epub 2001 Aug 16.

6/19/2001
Lin HK, Yeh S, Kang HY, Chang C. "Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor." Proceedings of the National Academy of Sciences of the United States of America.. 2001 Jun 19; 98(13):7200-5. Epub 2001 Jun 12.

3/13/2001
Kang HY, Lin HK, Hu YC, Yeh S, Huang KE, Chang C. "From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 2001 Mar 13; 98(6):3018-23. Epub 2001 Mar 06.

2001
Sampson ER, Yeh SY, Chang HC, Tsai MY, Wang X, Ting HJ, Chang C. "Identification and characterization of androgen receptor associated coregulators in prostate cancer cells." Journal of biological regulators and homeostatic agents.. 2001 15(2):123-9.

12/2000
Yeh S, Sampson ER, Lee DK, Kim E, Hsu CL, Chen YL, Chang HC, Altuwaijri S, Huang KE, Chang C. "Functional analysis of androgen receptor N-terminal and ligand binding domain interacting coregulators in prostate cancer." Journal of the Formosan Medical Association = Taiwan yi zhi.. 2000 Dec 0; 99(12):885-94.

10/10/2000
Yeh S, Hu YC, Rahman M, Lin HK, Hsu CL, Ting HJ, Kang HY, Chang C. "Increase of androgen-induced cell death and androgen receptor transactivation by BRCA1 in prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 2000 Oct 10; 97(21):11256-61.

10/1999
Yeh S, Kang HY, Miyamoto H, Nishimura K, Chang HC, Ting HJ, Rahman M, Lin HK, Fujimoto N, Hu YC, Mizokami A, Huang KE, Chang C. "Differential induction of androgen receptor transactivation by different androgen receptor coactivators in human prostate cancer DU145 cells." Endocrine.. 1999 Oct 0; 11(2):195-202.

9/28/1999
Chang HC, Miyamoto H, Marwah P, Lardy H, Yeh S, Huang KE, Chang C. "Suppression of Delta(5)-androstenediol-induced androgen receptor transactivation by selective steroids in human prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 1999 Sep 28; 96(20):11173-7.

6/4/1999
Heinlein CA, Ting HJ, Yeh S, Chang C. "Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma." The Journal of biological chemistry.. 1999 Jun 4; 274(23):16147-52.

6/1999
Heinlein CA; Ting HJ; Yeh S; Chang C. "Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma". J Biol Chem. 1999; .

6/1999
Yeh S, Chang HC, Miyamoto H, Takatera H, Rahman M, Kang HY, Thin TH, Lin HK, Chang C. "Differential induction of the androgen receptor transcriptional activity by selective androgen receptor coactivators." The Keio journal of medicine.. 1999 Jun 0; 48(2):87-92.

5/15/1999
Yang CR, Yeh S, Leskov K, Odegaard E, Hsu HL, Chang C, Kinsella TJ, Chen DJ, Boothman DA. "Isolation of Ku70-binding proteins (KUBs)." Nucleic acids research.. 1999 May 15; 27(10):2165-74.

5/11/1999
Yeh S, Lin HK, Kang HY, Thin TH, Lin MF, Chang C. "From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 1999 May 11; 96(10):5458-63.

5/1999
Yeh S; Lin HK; Kang HY; Thin TH; Lin MF; Chang C. "From HER2/Neu signal cascade to androgen receptor and its coactivators: a novel pathway by induction of androgen target genes through MAP kinase in prostate cancer cells." Proc Natl Acad Sci U S A. 1999; .

3/26/1999
Kang HY, Yeh S, Fujimoto N, Chang C. "Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor." The Journal of biological chemistry.. 1999 Mar 26; 274(13):8570-6.

3/19/1999
Fujimoto N, Yeh S, Kang HY, Inui S, Chang HC, Mizokami A, Chang C. "Cloning and characterization of androgen receptor coactivator, ARA55, in human prostate." The Journal of biological chemistry.. 1999 Mar 19; 274(12):8316-21.

9/15/1998
Miyamoto H, Yeh S, Lardy H, Messing E, Chang C. "Delta5-androstenediol is a natural hormone with androgenic activity in human prostate cancer cells." Proceedings of the National Academy of Sciences of the United States of America.. 1998 Sep 15; 95(19):11083-8.

7/20/1998
Yeh S, Miyamoto H, Nishimura K, Kang H, Ludlow J, Hsiao P, Wang C, Su C, Chang C. "Retinoblastoma, a tumor suppressor, is a coactivator for the androgen receptor in human prostate cancer DU145 cells." Biochemical and biophysical research communications.. 1998 Jul 20; 248(2):361-7.

6/23/1998
Miyamoto H, Yeh S, Wilding G, Chang C. "Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells." Proceedings of the National Academy of Sciences of the United States of America.. 1998 Jun 23; 95(13):7379-84.

6/1998
Miyamoto H; Yeh S; Wilding G; Chang C. "Promotion of agonist activity of antiandrogens by the androgen receptor coactivator, ARA70, in human prostate cancer DU145 cells." Proc Natl Acad Sci U S A. 1998; .

5/12/1998
Yeh S, Miyamoto H, Shima H, Chang C. "From estrogen to androgen receptor: a new pathway for sex hormones in prostate." Proceedings of the National Academy of Sciences of the United States of America.. 1998 May 12; 95(10):5527-32.

3/22/1997
Yeh S, Miyamoto H, Chang C. "Hydroxyflutamide may not always be a pure antiandrogen." Lancet.. 1997 Mar 22; 349(9055):852-3.

5/28/1996
Yeh S, Chang C. "Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells." Proceedings of the National Academy of Sciences of the United States of America.. 1996 May 28; 93(11):5517-21.

4/1995
Ideta R; Yeh S; Lee Y; Adachi K; Takeda H; Su C; Saltzman A; Chang C. "Gene expression of the androgen repressed rat TR2 orphan receptor: a member of steroid receptor superfamily." Endocrine. 1995; .

1995
Chang C, Saltzman A, Yeh S, Young W, Keller E, Lee HJ, Wang C, Mizokami A. "Androgen receptor: an overview." Critical reviews in eukaryotic gene expression.. 1995 5(2):97-125.

6/21/1994
Chang C, Da Silva SL, Ideta R, Lee Y, Yeh S, Burbach JP. "Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily." Proceedings of the National Academy of Sciences of the United States of America.. 1994 Jun 21; 91(13):6040-4.

1/1994
Mizokami A, Yeh SY, Chang C. "Identification of 3',5'-cyclic adenosine monophosphate response element and other cis-acting elements in the human androgen receptor gene promoter." Molecular endocrinology.. 1994 Jan 0; 8(1):77-88.

Books & Chapters

2012
Chapter Title: Differential Functions of Stromal and Epithelial Androgen Receptor in Prostate Cancer Before and After Castration Resistant Stage. Advances in Rapid Sex-Steroid Action, New Challenges and New Chances
Book Title: Breast and Prostate Cancers
Author List: Lee SO, Lai KP, Yeh S, Chang C.
Published By: Springer2012

2010
Chapter Title: Estrogens and Estrogen Receptors in Prostate Development, Estrogenization, and Carcinogenesis
Book Title: Female Sex Hormones and Cancers
Author List: Chen M and Yeh S*
Edited By: George G. Chen
Published By: Nova Science Publishers Inc2010

2009
Chapter Title: Differential Roles of Androgen Receptor in Prostate Development and Cancer Progression
Book Title: Androgen Action in Prostate Cancer
Author List: Yeh S, Niu Y, Miyamoto H, Chang T, Chang C.
Edited By: Tindall D and Mohler J
Published By: World Scientific Publishing2009

2005
Chapter Title: Functions of Estrogen Receptor in Prosate and Prostate Cancer
Book Title: Prostate Cancer: Basic Mechanisms and Therapeutic Approaches
Author List: Yeh, S*, Chen, M., Ni, J., Yin, Y., Chang, C., Zhang, M., and Wen, X.
Published By: World Scientific Publishing2005

2005
Chapter Title: Roles of Vitamin E in Prostate and Prostate Cancer
Book Title: Prostate Cancer: Basic Mechanisms and Therapeutic Approaches
Author List: Yeh S*, Ni J, Chang E, Yin Y, and Chen M.
Published By: World Scientific Publishing2005

2005
Chapter Title: Study of androgen receptor roles in prostate cancer using mice lacking functional prostate androgen receptor
Book Title: Prostate Cancer: Basic Mechanisms and Therapeutic Approaches
Author List: Wu C, Yeh S, Xu Q, Yang Z, Chang P, Yu Y, and Chang C.
Published By: World Scientific Publishing2005

2002
Chapter Title: Nature Products and Environmental Androgens and Antiandrogens.
Book Title: Androgens and Androgen Receptor Mechanisms, Functions, and Clinical Applications
Author List: Wang MS, Yeh S, Su CY, Yang CY.
Published By: Kluwer Academic Publishers2002

2000
Chapter Title: Yeast two-hybrid screening of associated proteins and characterization of mutant androgen receptors
Book Title: Yeast Hybrid Technologies
Author List: Nishimura K, Sampson E, Yan S, Kim E, Wang X, Uemura H, Wang C, Fujimoto N, Kang H, Yeh S, and Chang C
Edited By: Zhu L and Hann G
Published By: Eaton Publishing2000

1997
Chapter Title: Androgen receptor coregulators
Book Title: Molecular Basis of Steroid Hormone Function - New Targets for Intervention
Author List: Yeh S, Miyamoto H, Huang S, Kinoshita H, Fujimoto N, Nishimura K, Inui S, Mizokami A, Uemura H, Chang C.
Published By: Springer1997